Jessica M. Le Gall
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Cancer risks for ATM variant heterozygotes.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 01, 2025
A functional assay to classify RB1 variants of uncertain significance.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: January 17, 2025
Wilms tumor characteristics in children with heterozygous germline DIS3L2 variants.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 22, 2024
Deciphering dual clinical entities associated with TP53 pathogenic variants: Insights from 53,085 HBOC panel analyses in French laboratories.
Journal: International journal of cancer
Published: September 26, 2024
The clinical value of optical genome mapping in the rapid characterization of RB1 duplication and 15q23q24.2 triplication, for more appropriate prenatal genetic counselling.
Journal: Molecular genetics & genomic medicine
Published: January 07, 2024
Male breast cancer: No evidence for mosaic BRCA1 promoter methylation involvement.
Journal: Breast (Edinburgh, Scotland)
Published: November 17, 2023
Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of RB1 Alterations in Aqueous Humor.
Journal: Ocular oncology and pathology
Published: April 03, 2023
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood.
Journal: Clinical genetics
Published: January 19, 2023
Germline HPF1 retrogene insertion in RB1 gene involved in cancer predisposition.
Journal: Journal of medical genetics
Published: December 09, 2022
APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings?
Journal: Journal of medical genetics
Published: July 05, 2022
Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants.
Journal: Gynecologic oncology reports
Published: July 13, 2021
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
Journal: American journal of human genetics
Published: June 15, 2021
Last Updated: 09/26/2026